- Latent TB Testing involves detecting dormant Mycobacterium tuberculosis bacteria in individuals without active TB symptoms. Common methods include the Tuberculin Skin Test (TST) and Interferon-Gamma Release Assays (IGRAs). These tests aim to identify latent infections and prevent progression to active TB
- Immunocompromised individuals, such as those with HIV/AIDS or undergoing organ transplants, are contributing to the rising demand for latent TB testing
- International organizations and governments are investing in TB control programs, promoting early detection and preventive measures for latent TB
- For instance, In April 2024, Revvity launched the Auto-Pure 2400 system to enhance the efficiency of latent TB testing, combining accuracy with streamlined workflows
- Globally, the latent TB testing market is poised for growth, driven by increasing awareness, technological advancements, and global efforts to combat tuberculosis effectively
